查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613423

Disulfiram市場：依適應症、通路分類 - 全球預測 2025-2030

Disulfiram Market by Indication (Alcoholism Treatment, Co-occurring Disorders), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年Disulfiram市場價值為3.7519億美元，預計2024年將達到3.9275億美元，複合年成長率為4.81%，預計到2030年將達到5.2163億美元。

Disulfiram主要用於治療慢性酒精中毒，透過在攝取酒精時引起不愉快的反應而具有抑制飲酒的作用。這種藥物的需求在於它作為綜合成癮治療工具的作用，幫助患者保持清醒。它的用途主要是在醫療領域，由醫療保健專業人員為患有酒精依賴的患者開處方。最終用途應用範圍顯著擴展到醫療保健行業，包括醫院、復健中心和家庭護理場所。Disulfiram市場的成長受到人們對酒精相關疾病的認知不斷提高、全球酒精成癮盛行率上升以及優先考慮心理健康的社會轉變的影響。最近的機會包括在酒精消費量高的新興市場的潛在擴張以及整合到提供遠端醫療和遠端患者監護的數位醫療平台。一項策略建議是探索與科技公司的合作關係，開發創新的輸送系統，例如植入物和聯合治療，以提高依從性和療效。

主要市場統計
基準年[2023] 37519萬美元
預計年份 [2024] 3.9275億美元
預測年份 [2030] 52163萬美元
複合年成長率（%） 4.81%

然而，由於與Disulfiram使用相關的副作用以及具有不同作用機制的替代療法的可用性，患者猶豫不決，市場面臨限制。這些挑戰凸顯了對Disulfiram的功效和益處進行持續教育的必要性。潛在的創新領域包括最大限度地減少副作用的客製化給藥方案、先進的藥物傳遞系統以及影響藥物代謝的遺傳因素的研究，以更好地制定個人化治療計劃。此外，探索Disulfiram治療其他疾病的潛力，例如在初步研究中顯示出前景的某些癌症，可能會開拓新的細分市場。市場呈現動態性，主要來自非專利製造商的適度競爭。市場參與者可以透過投資研發來改進配方和給藥方法、加強其藥物的治療概況和市場地位來獲得優勢。

市場動態：揭示快速發展的Disulfiram市場的關鍵市場洞察

Disulfiram市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界各地酗酒者人數不斷增加
    • 提高患者意識和治療諮詢率
  • 市場限制因素
    • 與使用Disulfiram相關的副作用
  • 市場機會
    • 各國政府為遏制飲酒所做的積極努力
    • 藥物傳遞系統的創新，包括更有效的口服製劑
  • 市場挑戰
    • Disulfiram功效問題

波特的五力戰略工具駕馭Disulfiram市場

波特的五力架構是了解Disulfiram市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解Disulfiram市場的外部影響

外部宏觀環境因素對Disulfiram市場表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解Disulfiram市場的競爭狀況

對Disulfiram市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣Disulfiram市場供應商的績效評估

FPNV定位矩陣是評估Disulfiram市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃Disulfiram市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對Disulfiram市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 酒精成癮在世界呈現上升趨勢
      • 提高患者意識和治療就診率
    • 抑制因素
      • 與使用Disulfiram相關的副作用
    • 機會
      • 各國政府為遏制飲酒所做的積極努力
      • 藥物傳遞系統的創新，例如更有效的口服製劑
    • 任務
      • 與Disulfiram功效相關的問題
  • 市場區隔分析
    • 適應症：增加Disulfiram在慢性酒精成癮治療的使用
    • 分銷管道：醫療機構內的醫院藥房增加Disulfiram的供應
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章Disulfiram市場的適應症

  • 酒精成癮治療
  • 併發疾病

第7章Disulfiram市場：依分銷通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第8章 美洲Disulfiram市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區Disulfiram市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲Disulfiram市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 慶祝康復：SAMHSA 九月藥物使用和心理健康舉措的亮點
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Allergan plc
  • Aspen Pharmacare Holdings Limited
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Lupin Pharmaceuticals, Inc.
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • Odyssey pharmaceuticals inc
  • Par pharmaceutical inc
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Watson laboratories Inc.
  • Zydus Lifesciences Limited
Product Code: MRR-CD5A9334CF54

The Disulfiram Market was valued at USD 375.19 million in 2023, expected to reach USD 392.75 million in 2024, and is projected to grow at a CAGR of 4.81%, to USD 521.63 million by 2030.

Disulfiram, primarily used for treating chronic alcoholism, acts by deterring consumption through unpleasant reactions when alcohol is ingested. This medication's necessity lies in its role as a tool in comprehensive addiction therapy, helping patients maintain sobriety. The application is predominantly in the medical domain, prescribed by healthcare professionals for individuals struggling with alcohol dependence. The end-use scope largely encompasses the healthcare industry, including hospitals, rehabilitation centers, and home care settings. Market growth for disulfiram is influenced by rising awareness of alcohol-related disorders, increased incidence of alcoholism globally, and a societal shift towards mental health prioritization. Latest opportunities include potential expansion in emerging markets where alcohol consumption is significant, coupled with integration into digital health platforms offering telemedicine and remote patient monitoring. A strategic recommendation is to explore collaborations with technology firms to develop innovative delivery systems such as implantable forms or combination therapies that increase compliance and efficacy.

KEY MARKET STATISTICS
Base Year [2023] USD 375.19 million
Estimated Year [2024] USD 392.75 million
Forecast Year [2030] USD 521.63 million
CAGR (%) 4.81%

However, the market faces limitations due to side effects associated with disulfiram use, which can deter patients, and the availability of alternative therapies that offer different mechanisms of action. These challenges emphasize the necessity for ongoing education about disulfiram's efficacy and benefits. Potential areas for innovation include research into tailored dosing regimens that minimize side effects, advanced drug delivery systems, and the study of genetic factors influencing drug metabolism to better personalize treatment plans. Additionally, exploring disulfiram's potential in treating other conditions, such as certain cancers where it has shown promise in preliminary studies, could open new market segments. The market demonstrates a dynamic nature with moderate competition, primarily driven by generic manufacturers. Market players could gain an edge by investing in R&D to improve formulation and delivery methods, strengthening the drug's therapeutic profile and market standing.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Disulfiram Market

The Disulfiram Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing cases of alcohol addiction across the globe
    • Increasing patient awareness and higher treatment-seeking rate
  • Market Restraints
    • Side effects associated with the use of disulfiram
  • Market Opportunities
    • Favorable efforts from the governments to curb the use of alcohol
    • Innovations in drug delivery systems, such as more efficient oral formulations
  • Market Challenges
    • Issues associated with the effectiveness of disulfiram

Porter's Five Forces: A Strategic Tool for Navigating the Disulfiram Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Disulfiram Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Disulfiram Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Disulfiram Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Disulfiram Market

A detailed market share analysis in the Disulfiram Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Disulfiram Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Disulfiram Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Disulfiram Market

A strategic analysis of the Disulfiram Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Disulfiram Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alkem Laboratories Ltd., Allergan plc, Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Lupin Pharmaceuticals, Inc., Merck KGaA, Mylan N.V., Novartis AG, Odyssey pharmaceuticals inc, Par pharmaceutical inc, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Watson laboratories Inc., and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Disulfiram Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Alcoholism Treatment and Co-occurring Disorders.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing cases of alcohol addiction across the globe
      • 5.1.1.2. Increasing patient awareness and higher treatment-seeking rate
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with the use of disulfiram
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable efforts from the governments to curb the use of alcohol
      • 5.1.3.2. Innovations in drug delivery systems, such as more efficient oral formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with the effectiveness of disulfiram
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Rising usage of disulfiram for the treatment of chronic alcoholism
    • 5.2.2. Distribution Channel: Rising availability of disulfiram in hospital pharmacies which are located within medical facilities
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Disulfiram Market, by Indication

  • 6.1. Introduction
  • 6.2. Alcoholism Treatment
  • 6.3. Co-occurring Disorders

7. Disulfiram Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Disulfiram Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Disulfiram Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Disulfiram Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Celebrating Recovery: Highlighting SAMHSA's September Initiative on Substance Use and Mental Health
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alkem Laboratories Ltd.
  • 3. Allergan plc
  • 4. Aspen Pharmacare Holdings Limited
  • 5. Aurobindo Pharma Limited
  • 6. Bausch Health Companies Inc.
  • 7. Bayer AG
  • 8. Cipla Inc.
  • 9. Dr. Reddy's Laboratories Ltd.
  • 10. Eli Lilly and Company
  • 11. Lupin Pharmaceuticals, Inc.
  • 12. Merck KGaA
  • 13. Mylan N.V.
  • 14. Novartis AG
  • 15. Odyssey pharmaceuticals inc
  • 16. Par pharmaceutical inc
  • 17. Pfizer Inc.
  • 18. Sanofi S.A.
  • 19. Sun Pharmaceutical Industries Ltd.
  • 20. Torrent Pharmaceuticals Ltd.
  • 21. Watson laboratories Inc.
  • 22. Zydus Lifesciences Limited

LIST OF FIGURES

  • FIGURE 1. DISULFIRAM MARKET RESEARCH PROCESS
  • FIGURE 2. DISULFIRAM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DISULFIRAM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DISULFIRAM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DISULFIRAM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DISULFIRAM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DISULFIRAM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DISULFIRAM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DISULFIRAM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DISULFIRAM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DISULFIRAM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DISULFIRAM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DISULFIRAM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DISULFIRAM MARKET DYNAMICS
  • TABLE 7. GLOBAL DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DISULFIRAM MARKET SIZE, BY ALCOHOLISM TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DISULFIRAM MARKET SIZE, BY CO-OCCURRING DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DISULFIRAM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DISULFIRAM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DISULFIRAM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES DISULFIRAM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM DISULFIRAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. DISULFIRAM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. DISULFIRAM MARKET, FPNV POSITIONING MATRIX, 2023